Comparison of Computed Tomography Perfusion and Magnetic Resonance Imaging Perfusion-Diffusion Mismatch in Ischemic Stroke

Background and Purpose— Perfusion imaging has the potential to select patients most likely to respond to thrombolysis. We tested the correspondence of computed tomography perfusion (CTP)-derived mismatch with contemporaneous perfusion-diffusion magnetic resonance imaging (MRI). Methods— Acute ischemic stroke patients 3 to 6 hours after onset had CTP and perfusion-diffusion MRI within 1 hour, before thrombolysis. Relative cerebral blood flow (relCBF) and time to peak of the deconvolved tissue residue function (Tmax) were calculated. The diffusion lesion (diffusion-weighted imaging) was registered to the CTP slabs and manually outlined to its maximal visual extent. Volumetric accuracy of CT-relCBF infarct core (compared with diffusion-weighted imaging) was tested. To reduce false-positive low CBF regions, relCBF core was restricted to voxels within a relative time-to-peak (relTTP) >4 seconds for lesion region of interest. The MR-Tmax >6 seconds perfusion lesion was automatically segmented and registered to CTP. Receiver-operating characteristic analysis determined the optimal CT-Tmax threshold to match MR-Tmax >6 seconds. Agreement of these CT parameters with MR perfusion-diffusion mismatch in coregistered slabs was assessed (mismatch ratio >1.2, absolute mismatch >10 mL, infarct core <70 mL). Results— In analysis of 49 patients (mean onset to CT, 213 minutes; mean CT to MR, 31 minutes), constraining relCBF <31% within the automated relTTP perfusion lesion region of interest reduced the median magnitude of volumetric error (vs diffusion-weighted imaging) from 47.5 mL to 15.8 mL (P<0.001). The optimal CT-Tmax threshold to match MR-Tmax >6 seconds was 6.2 seconds (95% confidence interval, 5.6–7.3 seconds; sensitivity, 91%; specificity, 70%; area under the curve, 0.87). Using CT-Tmax >6 seconds “penumbra” and relTTP-constrained relCBF “core,” CT-based and MRI-based mismatch status was concordant in 90% (kappa=0.80). Conclusions— Quantitative CTP mismatch classification using relCBF and Tmax is similar to perfusion-diffusion MRI. The greater accessibility of CTP may facilitate generalizability of mismatch-based selection in clinical practice and trials.

[1]  Geoffrey A. Donnan,et al.  A Multicentre, Randomized, Double-Blinded, Placebo-Controlled Phase III Study to Investigate Extending the Time for Thrombolysis in Emergency Neurological Deficits (EXTEND) , 2012, International journal of stroke : official journal of the International Stroke Society.

[2]  R. Bammer,et al.  The Infarct Core is Well Represented by the Acute Diffusion Lesion: Sustained Reversal is Infrequent , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Bruce C V Campbell,et al.  Cerebral Blood Flow Is the Optimal CT Perfusion Parameter for Assessing Infarct Core , 2011, Stroke.

[4]  R. Gonzalez,et al.  CT Cerebral Blood Flow Maps Optimally Correlate With Admission Diffusion-Weighted Imaging in Acute Stroke but Thresholds Vary by Postprocessing Platform , 2011, Stroke.

[5]  H. An,et al.  Signal Evolution and Infarction Risk for Apparent Diffusion Coefficient Lesions in Acute Ischemic Stroke Are Both Time- and Perfusion-Dependent , 2011, Stroke.

[6]  Patrick McElduff,et al.  Defining the Extent of Irreversible Brain Ischemia Using Perfusion Computed Tomography , 2010, Cerebrovascular Diseases.

[7]  W. Heiss,et al.  Maps of Time to Maximum and Time to Peak for Mismatch Definition in Clinical Stroke Studies Validated With Positron Emission Tomography , 2010, Stroke.

[8]  P. Barber,et al.  Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch , 2010, Neurology.

[9]  R. Edelman,et al.  Evidence-based guideline: The role of diffusion and perfusion MRI for the diagnosis of acute ischemic stroke , 2010, Neurology.

[10]  Patrick McElduff,et al.  Pretreatment Diffusion- and Perfusion-MR Lesion Volumes Have a Crucial Influence on Clinical Response to Stroke Thrombolysis , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[11]  W. Hacke,et al.  Mismatch-Based Delayed Thrombolysis: A Meta-Analysis , 2010, Stroke.

[12]  Geoffrey A. Donnan,et al.  Optimal Perfusion Thresholds for Prediction of Tissue Destined for Infarction in the Combined EPITHET and DEFUSE Dataset , 2010 .

[13]  KimMouridsen,et al.  Comparison of 10 Perfusion MRI Parameters in 97 Sub-6-Hour Stroke Patients Using Voxel-Based Receiver Operating Characteristics Analysis , 2009 .

[14]  R. Gonzalez,et al.  MRI-Based Selection for Intra-Arterial Stroke Therapy: Value of Pretreatment Diffusion-Weighted Imaging Lesion Volume in Selecting Patients With Acute Stroke Who Will Benefit From Early Recanalization , 2009, Stroke.

[15]  Kim Mouridsen,et al.  Comparison of 10 Perfusion MRI Parameters in 97 Sub-6-Hour Stroke Patients Using Voxel-Based Receiver Operating Characteristics Analysis , 2009, Stroke.

[16]  R. Bammer,et al.  Optimal Tmax Threshold for Predicting Penumbral Tissue in Acute Stroke , 2009, Stroke.

[17]  G. Donnan,et al.  Breaking the 3 h barrier for treatment of acute ischaemic stroke , 2008, The Lancet Neurology.

[18]  M. Moseley,et al.  Optimal Definition for PWI/DWI Mismatch in Acute Ischemic Stroke Patients , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  Max Wintermark,et al.  The anterior cerebral artery is an appropriate arterial input function for perfusion-CT processing in patients with acute stroke , 2008, Neuroradiology.

[20]  Reto Meuli,et al.  Perfusion-CT Assessment of Infarct Core and Penumbra: Receiver Operating Characteristic Curve Analysis in 130 Patients Suspected of Acute Hemispheric Stroke , 2006, Stroke.

[21]  Søren Christensen,et al.  Automatic selection of arterial input function using cluster analysis , 2006, Magnetic resonance in medicine.

[22]  M. O’Sullivan,et al.  Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis , 2002, Neurology.

[23]  C. Ascaso,et al.  Effects of Thyroid Hormone on mRNAs of Phosphoglycerate Mutase Subunits in Rat Muscle during Development , 2002, Hormone Research in Paediatrics.

[24]  S. Warach New imaging strategies for patient selection for thrombolytic and neuroprotective therapies , 2001, Neurology.

[25]  Olaf B. Paulson,et al.  Quantitation of Regional Cerebral Blood Flow Corrected for Partial Volume Effect Using O-15 Water and PET: I. Theory, Error Analysis, and Stereologic Comparison , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  H S Markus,et al.  Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI , 2000, Journal of neurology, neurosurgery, and psychiatry.

[27]  M. Cowan,et al.  American Heart Association. , 2018, P & T : a peer-reviewed journal for formulary management.

[28]  Kirk H. Stone,et al.  A Preliminary Summary , 1973 .

[29]  R. Russell,et al.  Regional blood flow in the normal cerebral hemisphere. , 1969, Journal of neurology, neurosurgery, and psychiatry.

[30]  K. Hoedt-Rasmussen,et al.  REGIONAL CEREBRAL BLOOD FLOW IN MAN MEASURED EXTERNALLY FOLLOWING INTRA‐ARTERIAL ADMINISTRATION OF 85Kr OR 133Xe DISSOLVED IN SALINE , 1965 .

[31]  J Risberg,et al.  NORMAL VALUES OF REGIONAL CEREBRAL BLOOD FLOW IN MAN, INCLUDING FLOW AND WEIGHT ESTIMATES OF GRAY AND WHITE MATTER , 1965, Acta neurologica Scandinavica. Supplementum.

[32]  K. Hoedt-Rasmussen,et al.  Regional cerebral flow in man measured externally following intra-arterial administration of 85-Kr or 133-Xe dissolved in saline. , 1965, Acta neurologica Scandinavica. Supplementum.

[33]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.